Sana Biotechnology, Inc. SANA
2.43 USD -0.03 (-1.42%)
At closeNov 11, 2026, 6:02 AM EST
2.40 -0.03 -1.23%
Pre-market · Nov 11, 6:02 AM ET
2.32 Day range 2.52
2.22 52-week range 5.49
- YTD
- -40.29%
- 1 year
- -42.69%
News
benzinga.com Sana Biotechnology Q3 Adj. EPS $(0.14) Beats $(0.15) Estimate Sana Biotechnology (NASDAQ:SANA) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.15) by 6.67 percent. This is a 6.67 percent increase over losses of…
globenewswire.com Sana Biotechnology Reports Third Quarter 2026 Financial Results and Business Updates Continued progress toward starting SC451 Phase 1/2 trial in type 1 diabetes Continued progress toward starting clinical study for SG293 in non-Hodgkin lymphoma Announced follow-on publication in The…